December 3, 2021
AstraZeneca Nixes $8.1 Billion Deal to Take Swedish Orphan Biovitrum Private
Read More
December 3, 2021
Recordati to Acquire EUSA Pharma for $847 Million to Expand Rare Disease Offerings
Read More
December 3, 2021
Regulators Approve BeiGene’s and EUSA Pharma’s Sylvant in China for Idiopathic Multicentric Castleman Disease
Read More
December 3, 2021
Stoke Reports Early Efficacy Signals from Dravet Syndrome Study
Read More
December 2, 2021
Rare Leader: Megan Golden, CEO and Co-Founder, Mission: Cure
Read More
December 2, 2021
AviadoBio Raises $80 million to Advance Neurodegenerative Gene Therapy Platform
Read More
December 2, 2021
Krystal Biotech Raises $200 Million in Public Offering to Advance Redosable Gene Therapies
Read More
December 2, 2021
Tune Therapeutics Launches with Epigenomic Control Platform to Master Gene Networks
Read More
December 2, 2021
Astellas and Dyno Partner to Develop Next-Generation AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle
Read More
December 2, 2021
GBT Grants $400,000 to Help Expand Sickle Cell Real-World Data Gathering in United States
Read More
December 1, 2021
Vertex Reports Positive Results from Phase 2 Study of VX-147 in APOL1-Mediated FSGS
Read More
Load More
X